Which organs it reaches

Each kidney holds about a million tiny blood-filtering units called glomeruli. These units make a fine distinction: they let waste and extra water through, keep useful protein in the blood. The membrane behind it works like a filter, thin even beside a strand of hair.

When sugar runs high for long, this order breaks down. Early on, many people’s filters work overtime; pressure inside rises and they strain blood faster than normal. The speedup looks harmless from outside, yet raises tension on the membrane. Over the years the membrane thickens, the cells around the filter wear out, and the filter’s old selectivity fades.

When the membrane starts leaking, the first protein into the urine is albumin. At first the amount is so small an ordinary urine test misses it. This picture is called microalbuminuria; current kidney guidelines call the same thing moderately increased albuminuria. A small sample of your first morning urine is enough.

The second measure is the filtering rate itself. The lab combines the creatinine level in a tube of blood from your arm with age and sex to calculate eGFR. The leading e means “estimated,” because no device measures the filtering rate directly.

Weaker filtering has one more consequence touching daily life. Insulin in the blood and some diabetes medications the kidney clears leave more slowly than before, so their effects last longer than expected. The kidney-side change therefore also raises the risk of low blood sugar. “Why does blood sugar drop?” gathers the reasons.

Why do these two measurements gain meaning together? Because damage doesn’t follow the same order in everyone: in some, filtering power drops without albumin in the urine rising at all. Looking at only one misses that person’s change entirely. One high result isn’t enough either; fever, a urinary tract infection, or recent hard exercise can raise albumin temporarily. Not one result, but several together, carry the meaning.

Blood pressure’s weight here is its own heading. Because the filter units are pressure-sensitive, high blood pressure pulls the already raised internal pressure higher still. Sugar and blood pressure load two separate burdens onto the same vascular bed. That’s also why the arm cuff appears so often in kidney monitoring.

For a long time diabetic nephropathy gives no complaint at all: no pain, no change in the urine’s look, no tiredness of its own. So monitoring checks urine and blood at regular intervals, without waiting for one.

The advanced stage, though, has its own signs. Swelling in the ankles and eyelids, heavily foamy urine, falling appetite, and unexplained exhaustion belong to this group. These are signs not of the early period but of a picture well along. The meaning of the silence sits right here.

The course isn’t one-way, but the two directions don’t weigh the same. In a study following people with type 2 diabetes for years, albumin that rose early returned to normal in one group. Still, in the whole group, progression outweighed reversal (Qiao et al., 2025). A change noticed early has a course to follow; that’s where measuring’s value sits.

A healthy artery’s inside is lined with a slick single row of cells. When that lining frays, blood cholesterol particles seep into the wall and stay. Immune cells come to clean up, take on fat, and can’t leave the spot. In time the deposit becomes a plaque under a fibrous, hard cap.

The vessel narrows, but narrowing itself isn’t the main event. The breaking point: that cap thins and tears, and blood begins to clot the moment the tear opens. The vessel can block quickly. What’s called a heart attack is most often the result of a sudden blockage, not a slow narrowing.

Diabetes touches not one link in this chain but several at once. The vessel’s inner lining loses function early, platelets clump more easily, and the resulting clot is hard to dissolve. The blood’s fat mix shifts too; small, dense particles enter the wall more easily. The result: an earlier, more widespread plaque load than in someone the same age.

The truly important point starts here. Autonomic nerves wrapped around the heart carry its pain news, and in diabetes they can wear down. The news weakens or never arrives. A large review pooling twenty-two studies found people with diabetes come in during a heart attack without chest pain markedly more often (Kumar et al., 2023). In a large study following adults with type 2 diabetes, the “silent” heart attack was also seen more often in people with reduced heart rate variability.

As pain fades the picture takes other disguises; the recognizable signs are these:

• Breath cut short on a familiar slope or a few stairs
• Chest pressure, tightness, or fullness rather than pain
• Vague discomfort striking the jaw, neck, shoulder, arm, or between the shoulder blades
• Heaviness like indigestion over the stomach, nausea
• Cold sweat for no reason, sudden weakness, dimming vision

These signs share one thing: they’re easily blamed on something else (tiredness, age, or a heavy meal). In diabetes there’s one more trap: cold sweat, weakness, and dimming vision are also low blood sugar’s language. If these persist even after the low sugar is corrected, the explanation is sought elsewhere.

The telling point is newness and timing. If something never felt before comes on with exertion and eases with rest, the heart enters that picture too. In someone whose nerves have worn down this feeling may never arise; that’s why an old attack’s trace turning up later on an EKG isn’t rare.

There are two separate time scales here. The picture that comes with exertion and goes with rest spans weeks. If the same signs start suddenly together and don’t ease with rest, the scale changes: once the vessel blocks, heart muscle takes damage in minutes and hours. The second isn’t watched and waited on; it’s assessed urgently.

It’s no coincidence blood pressure and blood fats sit in the same picture. All three strain the same vessel wall, and their effects stack. Monitoring only sugar closes without seeing most of the picture. What does following all three together change? “What else gets checked besides blood sugar?” answers it.

Silence isn’t a guarantee here. It only means the news didn’t arrive. That’s also why the heart is among the headings followed before any complaint.

Blood reaches every organ through vessels, and a thin cell layer, the endothelium, lines them inside. Glucose running high for long wears this layer first: inflammatory processes quicken, oxidative load rises, the vessel’s power to relax drops. In most organs damage starts here. Nerves stand apart: affected both by the feeding capillary and directly by the metabolic load. Which organ gets in line depends on where in the body that vessel feeds.

The vessel network isn’t one size; wear builds on two separate scales, by two separate mechanisms. In capillaries the basement membrane thickens, capillaries clog, vanish one by one; blood to the tissue they feed drops. This scale covers the eye’s retina, the kidney’s filtering units, the nerves’ feeding vessels. In large arteries the picture differs: fatty plaque builds in the wall, the vessel narrows, clotting tendency rises. Heart, brain and leg arteries sit on this side. The heart-and-vessels piece covers how plaque is built, and why the real break comes at the moment of tearing.

Timing differs too. The capillary side is the one tied most tightly to glucose; the link between average sugar and risk here is the strongest measured. On the large-vessel side glucose isn’t the only factor; blood pressure and blood fats weigh at least as much. In type 2 diabetes large-vessel wear has often begun before the name is given; even at borderline sugar, heart and vessel risk has already risen. One gathers quietly, the other announces itself with a single event.

Silence is this map’s hardest part. Capillary damage starting out neither hurts nor spoils vision; the person feels fine while the vessels have started changing. So the early stage is caught by looking, not feeling: the eye’s back examined, urine checked for albumin, the foot tested for sensation. On the large-vessel side the first trace often shows in a moment of exertion. Chest tightness climbing stairs, calf pain that starts on walking and passes on stopping, one foot staying markedly colder than the other.

Are all organs affected at once?

No, the two scales keep separate clocks. In one person eye involvement can be marked while the kidney’s filtering power holds. In the same person the large-vessel side can advance soundlessly.

How long does damage take to build up?

There is no single calendar. Blood pressure, blood fats and smoking weigh as much as time does. Because type 2 diabetes stays quiet for long, in some people eye or kidney involvement has already begun at diagnosis.

Is the brain on this map too?

Yes, on the large-vessel side. The same plaque process runs in the brain’s feeding arteries; raised stroke risk comes from there. A stroke announces itself suddenly, not gradually: one side of the face dropping, weakness appearing in one arm, speech breaking down, sight going in one eye. This picture is measured in minutes and needs urgent medical assessment.

The map ends here; the road itself doesn’t. Every organ has its own signs, own way of being looked at, own time scale; separate pieces open each in turn. The common point: eye, kidney, nerve, heart and leg look like far-apart organs, yet they are different addresses in the same vessel story.

The retina is the thin mesh lining the eye’s back wall; cells turning light into signal sit there. The body’s finest capillaries feed this layer. Glucose staying high for long weakens those capillary walls: support cells vanish, the basement membrane thickens. Once permeable, the wall leaks fluid and protein into the retina; the same process clogs some capillaries outright.

The clogged patch goes without oxygen and the retina calls for help; released growth signals build new vessels. Trouble is, these new vessels are fragile and bleed: diabetic retinopathy’s advanced stage. When bleeding spreads inside the eye, the picture blurs suddenly or floating black spots appear.

Macular edema is its own heading. The macula is the sharp-vision zone dead center in the retina; you read phone screens, faces, and print there. Leaking fluid pooling there thickens the retina, dulling central vision. It’s the main cause of declining vision in diabetes, and comes without waiting for retinopathy’s advanced stage.

The early stage’s most misleading side: its silence. Capillaries have begun changing, yet sharp vision stays whole; reading and driving hold up. So retinopathy is caught by looking, not complaints. In the dilated eye exam, drops widen the pupil, then the doctor views the retina with a special light or retina camera. The doctor’s target is the vessels themselves: tiny balloonings in capillaries, pinpoint bleeds, yellowish spots left by leaking. American Diabetes Association standards of care bring this exam up with no symptom looked for; the screening article covers why the start shifts by diabetes type.

Once the eye speaks up, here’s what gets noticed:

• Dullness dead center in vision; straight lines looking wavy or broken
• Floating spots appearing suddenly, hair-like shadows, a reddish haze
• A curtain or fixed shadow dropping over a corner of the visual field
• More glare around car headlights at night, harder adjusting to the dark
• Blur noticed with one eye covered, absent in the other

Most of these signs settle over days. A sudden curtain, spots multiplying at once, or vision dropping fast in one eye stand apart. Bleeding inside the eye and a detaching retina move on a scale of hours and need urgent eye evaluation. What sets urgency isn’t the sign’s severity but its suddenness.

Is eye screening needed even with good vision?

Yes, and that’s exactly why: early retinopathy doesn’t affect vision. Capillary changes surface only when the retina is looked at; the person feels nothing then.

Is blurry vision always retinopathy?

No, there’s a passing kind too. When glucose changes fast, the eye lens’s water balance goes off, its focusing power shifts, the image isn’t sharp. Once glucose settles, the lens returns to its old state; that recovery takes weeks, so a glasses prescription measured in this stretch doesn’t count as settled. Retina-driven blur, meanwhile, comes with dullness at the center, distortion, or floating spots.

If blood sugar improves, does retinopathy reverse?

Some early-stage changes stall, even recede. New vessels formed in the advanced stage and macular damage don’t reverse on their own; treatment there aims to protect vision.

Retinopathy’s time scale is counted in years, and the early stage leaves no trace. So the eye’s most valuable information isn’t how it sees but how its back looks.